FDA's risk communication plan coming soon
This article was originally published in The Tan Sheet
Executive Summary
FDA could release its strategic plan to ensure it accurately communicates to consumers the risks and benefits of medical products in as early as one month, according to Janet Woodcock, director of the Center for Drug Evaluation and Research. The plan will include a list of 14 actions FDA will take in the next year to improve its risk communication strategies. It will also list around 60 actions FDA hopes to take in the next few years, Woodcock said Sept. 21 at the Food and Drug Law Institute conference in Washington